Monica Morrow - Concepedia

Author

Monica Morrow

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Beitsch, Peter D., Cordeiro, Peter G., M MORROW, M Morrow, M. Morrow, Monica A. Morrow, Monica Morrow, Morrow M

675

Publications

37.2K

Citations

H-Index

174

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Michigan Northwestern University University of Southern California Fox Chase Cancer Center

About

Monica Morrow is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	146	13.3K
2	Health Sciences	24	36	5.9K
3	Management	3	3	255
4	Engineering	2	2	50
5	Education	1	1	69

Monica Morrow

251

Publications

24.3K

Citations

H-Index

Page 1

	Year	Citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Annals of Oncology Surgical OncologyBreast OncologyCancer ManagementPrimary TherapyPathology	2013	3.6K
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Annals of Oncology	2015	1.8K
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants Pedram Razavi, Bob T. Li, David N. Brown, Nature Medicine Dna SequencingSequencingHigh-intensity SequencingSingle Cell SequencingCell-free Dna Variants	2019	718
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Sibylle Loibl, Fabrice André, Thomas Bachelot, Annals of Oncology Surgical OncologyBreast OncologyEarly Breast CancerMedicineCancer Management	2023	684
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer George Plitas, Catherine Konopacki, Kenmin Wu, Immunity Breast OncologyCancer ImmunosurveillanceT-regulatory CellImmunologyRegulatory T Cells	2016	682
Does aggressive local therapy improve survival in metastatic breast cancer? Seema A. Khan, Andrew K. Stewart, Monica Morrow Surgery Metastatic Breast CancerOncologyBreast OncologyBreast CancerCancer Treatment	2002	390
Factors Predicting the Use of Breast-Conserving Therapy in Stage I and II Breast Carcinoma Monica Morrow, Julia White, Jennifer Moughan, Journal of Clinical Oncology	2001	356
Patient Involvement in Surgery Treatment Decisions for Breast Cancer Steven J. Katz, Paula M. Lantz, Nancy K. Janz, Journal of Clinical Oncology	2005	329
Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy Tari A. King, Rita A. Sakr, Sujata Patil, Journal of Clinical Oncology	2011	324
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction Kala Visvanathan, Rowan T. Chlebowski, Patricia A. Hurley, Journal of Clinical Oncology	2009	286

Page 1